zoledronic acid has been researched along with Leukemia, Myeloid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashton, JM; Becker, MW; Calvi, LM; Frisch, BJ; Jordan, CT; Xing, L | 1 |
Idrees, AS; Inoue, C; Minato, N; Morita, CT; Murata-Hirai, K; Okamura, H; Sugie, T; Tanaka, Y; Toi, M | 1 |
Berlanga, J; Domingo, A; Español, I; Heras, L; Janáriz, J; Losa, F; Romagosa, V | 1 |
Braess, J; Fiegl, M; Hiddemann, W; Juergens, M | 1 |
4 other study(ies) available for zoledronic acid and Leukemia, Myeloid
Article | Year |
---|---|
Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.
Topics: Animals; Blotting, Western; Bone Density Conservation Agents; Bone Marrow; Bone Resorption; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chemokine CCL3; Diphosphonates; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Hematopoiesis; Humans; Imidazoles; Immunocompetence; Immunoenzyme Techniques; Leukemia, Myeloid; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Zoledronic Acid | 2012 |
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
Topics: Cell Line, Tumor; Cytotoxicity, Immunologic; Diphosphonates; Geranyltranstransferase; Hemiterpenes; HL-60 Cells; Humans; Imidazoles; K562 Cells; Leukemia, Myeloid; Lymphoma; MCF-7 Cells; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Tumor Necrosis Factor-alpha; U937 Cells; Zoledronic Acid | 2013 |
Zoledronate-induced remission of acute panmyelosis with myelofibrosis.
Topics: Acute Disease; Aged; Blood Cell Count; Blood Transfusion; Bone Marrow Examination; Diphosphonates; Humans; Imidazoles; Leukemia, Myeloid; Male; Primary Myelofibrosis; Remission Induction; Zoledronic Acid | 2004 |
Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia.
Topics: Acute Disease; Aged; Antineoplastic Agents; Bone Marrow Cells; Caspase 3; Cell Proliferation; Cytarabine; Diphosphonates; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid; Male; Middle Aged; Zoledronic Acid | 2007 |